secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ultragenyx Pharmaceutical Inc. (RARE)
CIK:        0001515673
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0000950170-23-072192
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultragenyx amends bylaws to align with Delaware law and SEC universal proxy card rules
--------------------------------------------------------------------------------

- Board approved Second Amended and Restated Bylaws effective December 15, 2023.
- Amendments reflect recent Delaware General Corporation Law changes and SEC universal proxy card rules.
- Reserves white proxy card for company's exclusive use; clarifies ability to disregard non-compliant nominations.
- Includes administrative, ministerial, clarifying and conforming changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1515673/000095017023072192/0000950170-23-072192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1515673/000095017023072192/rare-20231215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-072192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer